Himalaya Therapeutics Announces Highlights of Recent Clinica

/PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization of a novel class of...

Related Keywords

China , Shanghai , Nicholas Desjardins , Brian Zhang , Mecbotamab Vedotin , Ozuriftamab Vedotin , Bioatla Inc , Nasdaq , Pleomorphic Sarcoma , Dose Limiting Toxicities , Serious Adverse Events , Himalaya Therapeutics , Conditionally Active Biologics , Greater China , Operational Updates , Soft Tissue , Primary Bone , Escalation Trial , Across Multiple Solid Tumor Types , Himalaya Therapeutics Sezc ,